16-89749925-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000135.4(FANCA):​c.3067-23G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0769 in 1,612,260 control chromosomes in the GnomAD database, including 5,744 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.060 ( 417 hom., cov: 33)
Exomes 𝑓: 0.079 ( 5327 hom. )

Consequence

FANCA
NM_000135.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.123

Publications

8 publications found
Variant links:
Genes affected
FANCA (HGNC:3582): (FA complementation group A) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008]
FANCA Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-89749925-C-T is Benign according to our data. Variant chr16-89749925-C-T is described in ClinVar as [Benign]. Clinvar id is 255252.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCANM_000135.4 linkc.3067-23G>A intron_variant Intron 31 of 42 ENST00000389301.8 NP_000126.2 O15360-1
FANCANM_001286167.3 linkc.3067-23G>A intron_variant Intron 31 of 42 NP_001273096.1 O15360-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCAENST00000389301.8 linkc.3067-23G>A intron_variant Intron 31 of 42 1 NM_000135.4 ENSP00000373952.3 O15360-1

Frequencies

GnomAD3 genomes
AF:
0.0595
AC:
9062
AN:
152192
Hom.:
416
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0140
Gnomad AMI
AF:
0.0231
Gnomad AMR
AF:
0.0373
Gnomad ASJ
AF:
0.0579
Gnomad EAS
AF:
0.216
Gnomad SAS
AF:
0.0263
Gnomad FIN
AF:
0.0613
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0833
Gnomad OTH
AF:
0.0564
GnomAD2 exomes
AF:
0.0666
AC:
16695
AN:
250704
AF XY:
0.0658
show subpopulations
Gnomad AFR exome
AF:
0.0142
Gnomad AMR exome
AF:
0.0195
Gnomad ASJ exome
AF:
0.0584
Gnomad EAS exome
AF:
0.231
Gnomad FIN exome
AF:
0.0595
Gnomad NFE exome
AF:
0.0767
Gnomad OTH exome
AF:
0.0565
GnomAD4 exome
AF:
0.0787
AC:
114935
AN:
1459950
Hom.:
5327
Cov.:
32
AF XY:
0.0772
AC XY:
56094
AN XY:
726344
show subpopulations
African (AFR)
AF:
0.0113
AC:
378
AN:
33458
American (AMR)
AF:
0.0211
AC:
944
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0569
AC:
1488
AN:
26130
East Asian (EAS)
AF:
0.157
AC:
6246
AN:
39690
South Asian (SAS)
AF:
0.0220
AC:
1901
AN:
86218
European-Finnish (FIN)
AF:
0.0580
AC:
3085
AN:
53180
Middle Eastern (MID)
AF:
0.0138
AC:
74
AN:
5346
European-Non Finnish (NFE)
AF:
0.0863
AC:
95843
AN:
1110894
Other (OTH)
AF:
0.0825
AC:
4976
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
5419
10839
16258
21678
27097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3566
7132
10698
14264
17830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0595
AC:
9069
AN:
152310
Hom.:
417
Cov.:
33
AF XY:
0.0575
AC XY:
4279
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0140
AC:
580
AN:
41562
American (AMR)
AF:
0.0373
AC:
570
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0579
AC:
201
AN:
3472
East Asian (EAS)
AF:
0.217
AC:
1126
AN:
5188
South Asian (SAS)
AF:
0.0271
AC:
131
AN:
4832
European-Finnish (FIN)
AF:
0.0613
AC:
651
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0833
AC:
5668
AN:
68032
Other (OTH)
AF:
0.0568
AC:
120
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
437
874
1312
1749
2186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0451
Hom.:
44
Bravo
AF:
0.0572
Asia WGS
AF:
0.113
AC:
393
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 02, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia complementation group A Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.43
DANN
Benign
0.35
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17227057; hg19: chr16-89816333; COSMIC: COSV59795607; API